Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) announced that the journal of Epilepsy & Behavior Case Reports has accepted for publication a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE